еÃÀû

еÃÀû¿Æ¼¼Ó뿵ϣŵÉúÎï¸æ¿¢Õ½ÂÔÏàÖú ¹²Ì½mRNAÒßÃçÖ×ÁöÃâÒßмƻ®

2025-04-10

×ÖºÅ

       ¿ËÈÕ£¬£¬ £¬ÐµÃÀû¿Æ¼¼È«×Ê×Ó¹«Ë¾Ìì½òеÃÀû¿Æ¼¼ÓÐÏÞ¹«Ë¾£¨ÒÔϼò³Æ¡°ÐµÃÀû¿Æ¼¼¡±£©Ó뿵ϣŵÉúÎï×Ó¹«Ë¾¿µÏ£ÅµÉúÎÉϺ££©ÓÐÏÞ¹«Ë¾£¨ÒÔϼò³Æ¡°¿µÏ£ÅµÉúÎ£©Ç©ÊðÏàÖú¿ª·¢Ð­Ò飬£¬ £¬Ë«·½½«ÅäºÏÍƽømRNAÒßÃçÓÃÓÚÖÎÁƽºÖÊĸϸ°ûÁö£¨GBM£©µÄÁÙ´²Ñо¿ÏîÄ¿£¬£¬ £¬Ô¤¼Æ½ñÄêÄÚÍê³ÉÊ×Àý»¼Õ߸øÒ©¡£¡£ ¡£

       ÐµÃÀû¿Æ¼¼ºÍ¿µÏ£ÅµÉúÎïͬΪÌì½òºËËṤҵͬÃ˵ijÉÔ±µ¥Î»£¬£¬ £¬´ËÇ°Ë«·½ÔÚÒªº¦ÖÊÁÏÑз¢¼°½¹µãÊÖÒÕ֪ʶ²úȨ½á¹¹µÈÁìÓòÒѽ¨ÉèÓÅÒìÏàÖú»ù´¡¡£¡£ ¡£±¾´ÎÏàÖú½«³ä·ÖÑéչеÃÀû¿Æ¼¼ÔÚ¿¹Ö×ÁöÒ©Î￪·¢µÄ¸»ºñÂÄÀúÓ뿵ϣŵÉúÎïmRNAÊÖÒÕƽ̨µÄÐÛºñʵÁ¦£¬£¬ £¬Í¬Ê±Ò²ÎªË«·½ÔÚmRNAÒßÃçÖÎÁÆÖ×ÁöÁìÓòÉîÈë½»Á÷ºÍ½øÒ»²½ÏàÖúµÓÚ¨»ù´¡¡£¡£ ¡£

       ÐµÃÀû¿Æ¼¼ÖÕÄêרעÓÚÒ©ÎïµÝËÍÁìÓò£¬£¬ £¬ÔÚÖ×ÁöÃâÒß·½ÃæºÍmRNAµÝË͵ÈÆ«Ïò¾ùÓнṹ¡£¡£ ¡£ÐµÃÀû¿Æ¼¼×ÔÖ÷Ñз¢µÄ¾ÛÒÒ¶þ´¼ÒÁÁ¢Ì濵(JK1201I)ÖÎÁÆÒ»ÏßÏ£ÍûÆÕ±éÆÚСϸ°û·Î°©ÕýÔÚ¾ÙÐÐÁÙ´²ÈýÆÚÑо¿£¬£¬ £¬ÄÔ½ºÖÊÁö˳Ӧ֢Óë°éÄÔתÒƵÄÈýÒõÐÔÈéÏÙ°©Ë³Ó¦Ö¢ÕýÔÚ¾ÙÐÐÁÙ´²¶þÆÚÑо¿¡£¡£ ¡£

       ¿µÏ£ÅµÉúÎｨÉèµÄmRNAÊÖÒÕƽ̨£¬£¬ £¬ÓµÓÐ×ÔÖ÷Éè¼Æ¡¢¿ª·¢µÄÐòÁÐÓÅ»¯Èí¼þ£¬£¬ £¬¿É»ñµÃÓ°ÏìÎȹÌÐÔµÄÒªº¦Î»µã¼°ÓÐÓÃÌá¸ß¿¹Ô­±í´ïÁ¿µÄ×îÓÅÐòÁУ¬£¬ £¬CMC¹¤ÒÕ¾«Á·£¬£¬ £¬¿ÉÒÔËõ¶Ì²úÆ·¿ª·¢Ê±¼ä£¬£¬ £¬¿ìËÙʵÏÖ¿ÆÑÐЧ¹û¹¤Òµ»¯¡£¡£ ¡£

       ÐµÃÀû¿Æ¼¼½«ÒÀÍÐmRNAµÈÏȽøÊÖÒÕƽ̨£¬£¬ £¬³Ð¼ÌÒÔÖÊÁÏÁ¢ÒìÒýÁìÉúÎïÒ½Ò©Á¢ÒìµÄʹÃü£¬£¬ £¬Ò»Á¬Í¨¹ýÐÂÐÍÒ©ÎïµÝËÍÊÖÒÕΪÖ×ÁöÃâÒß¡¢»ùÒòÖÎÁƵÈÁìÓò´øÀ´¸ü¶àÓÐÖúÓÚÈ«·½Î»ÌáÉý»¼Õ߸£ÀûµÄ½â¾ö¼Æ»®£¬£¬ £¬Ð¯ÊÖЭ×÷ͬ°éÅäºÏÔö½ø¡°ÈËÈËÏíÓÐÎÀÉú¿µ½¡¡±Ä¿µÄµÄʵÏÖ¡£¡£ ¡£

 

¹ØÓÚ½ºÖÊĸϸ°ûÁö

½ºÖÊĸϸ°ûÁö£¨Ò²³ÆΪ¢ô¼¶ÐÇÐÎϸ°ûÁö£©ÊÇÌìÏÂÎÀÉú×éÖ¯È϶¨µÄIV¼¶½ºÖÊÁö£¬£¬ £¬Ò²ÊÇ×î³£¼ûµÄ¶ñÐÔÔ­·¢ÐÔÄÔÖ×Áö£¬£¬ £¬5ÄêÉúÑÄÂÊΪ7.2%¡£¡£ ¡£¸ÃÖ×ÁöÉú³¤Ñ¸ËÙ£¬£¬ £¬¶ñÐԶȸߣ¬£¬ £¬Ö÷ҪλÓÚ´óÄÔ°ëÇò£¬£¬ £¬Ò²¿É±¬·¢ÔÚÄԸɡ¢Ð¡ÄÔ°ëÇò»ò¼¹ËèµÈ£¬£¬ £¬Ö÷Òª·¢²¡ÄêËêΪ45-60Ë꣬£¬ £¬ÄÐÐÔ½ÏÅ®ÐÔ·¢²¡ÂÊÂԸߣ¬£¬ £¬¶ùͯҲ¿ÉÒÔ·¢²¡£¬£¬ £¬ÇÒ¶à¼ûÓÚÄԸɡ£¡£ ¡£GBMµÄ¸ß¶È½þÈóÐÔ¡¢ÒÅ´«ÒìÖÊÐÔºÍѪÄÔÆÁÕϵı£»£»£»¤¸øÖÎÁÆ´øÀ´ÁËÖØ´óµÄÌôÕ½¡£¡£ ¡£ÏÖÔÚGBMµÄ±ê×¼ÖÎÁÆÊÇÊÖÊõÇгýºó¾ÙÐзŻ¯ÁÆ¡£¡£ ¡£ÊÖÊõÇгýÖ×Áöºó¸´·¢½Ï¿ì£¬£¬ £¬ÆäÔ¤ºóÊÇÄÔ½ºÖÊÁöÖнϲîµÄÒ»ÖÖ¡£¡£ ¡£¡¾1¡¿

½üÄêÀ´ÃâÒßÁÆ·¨³ÉΪÐí¶àÖ×ÁöµÄÖ÷ÒªÖÎÁÆ·½·¨£¬£¬ £¬¿ÉÊÇÔÚÄÔ°©£¨°üÀ¨GBM£©µÄÖÎÁÆÉÐδȡµÃÍ»ÆÆ¡£¡£ ¡£È¥ÄêÍâÑó¼¸ÏîʹÓÃmRNAÒßÃçµÄСÐÍÁÙ´²ÊÔÑéµÄЧ¹ûËƺõŤתÁËÕâÒ»Ç÷ÊÆ£¬£¬ £¬Ïà¹ØµÄÑо¿±¨µÀÔÚNIHÉÏÓÐËù±¨µÀ[2]¡£¡£ ¡£Í¬Äêһƪ½ÒÏþÔÚJ NanobiotechnologyµÄ×ÛÊö»ã×ÜÁËmRNAÒßÃçÔÚGBMµÄÓ¦Óá¾3¡¿£¬£¬ £¬Õ¹Ê¾ÁËÖ÷ÒªµÄÖÎÁÆDZÁ¦¡£¡£ ¡£

 

¹ØÓÚеÃÀû¿Æ¼¼

еÃÀû£¨ÐµÃÀû¿Æ¼¼688356.SH£©½¨ÉèÓÚ2001Ä꣬£¬ £¬ÊÇÈ«ÇòÒ½ÓÃÒ©ÓþÛÒÒ¶þ´¼ÖÊÁÏÁìÓòµÄÖ÷ÒªÐÂÐ˼ÓÈëÕߣ¬£¬ £¬Îª¶à¿îÉÏÊÐPEG»¯Á¢ÒìÒ©Îï¼°Ò½ÁÆÆ÷е²úÆ·¹©Ó¦PEGÑÜÉúÎï¡£¡£ ¡£Í¬Ê±¿ª·¢Á˺£ÄÚµÚÒ»¿îPEGżÁªÐ¡·Ö×ÓÒ©Î£¬ £¬ÏÖÔÚ¸ÃÏîÄ¿´¦ÓÚÈýÆÚÁÙ´²½×¶Î¡£¡£ ¡£ÐµÃÀû¿Æ¼¼¾Û½¹mRNAµÝËÍϵͳ½¹µãÊÖÒÕ¹¥¹Ø£¬£¬ £¬ÔÚÒªº¦Ö¬ÖÊÖÊÁÏÁìÓòÈ¡µÃÖ÷ҪͻÆÆ£ºÍ¨¹ý¶ÔÏÖÓеÝËÍϵͳÖÐÒªº¦Ö¬ÖÊÒòËؾÙÐÐÉú²ú¹¤ÒÕÓÅ»¯£¬£¬ £¬ÊµÏÖÁË5ÖÖÒªº¦¸¨ÁϵĹæÄ£»£»£»¯×ÔÖ÷ÖƱ¸£¬£¬ £¬Ïà¹ØÊÖÒÕ×ÊÁÏÒÑͨ¹ý¹ú¼ÒÒ©¼à¾ÖÒ©Æ·ÉóÆÀÖÐÐÄ£¨CDE£©ºÍÃÀ¹úFDAµÄÖÊÁÏÒ©Ö÷Îļþ£¨DMF£©Ë«Öر¸°¸£»£»£»Í¬²½¹¹½¨ÁË°üÀ¨ÊýÊ®ÖÖÁ¢Òì½á¹¹µÄÖ¬ÖÊ»¯ºÏÎï¿â£¬£¬ £¬ÐγɾßÓÐ×ÔÖ÷֪ʶ²úȨµÄÊÖÒÕ¾ØÕ󡣡£ ¡£

 

¹ØÓÚ¿µÏ£ÅµÉúÎï

¿µÏ£ÅµÉúÎï¹É·Ý¹«Ë¾£¨¿µÏ£ÅµÉúÎï 06185.HK£»£»£»¿µÏ£Åµ 688185.SH£©£¬£¬ £¬2009Ä꽨ÉèÓÚÖйú£¬£¬ £¬ÖÂÁ¦ÓÚÔÚÌìϹæÄ£ÄÚÌṩԤ·ÀºÍÖÎÁÆѬȾÀ༲²¡µÄ½â¾ö¼Æ»®¡£¡£ ¡£¹«Ë¾ÏÖÓв¡¶¾ÔØÌåÒßÃçÊÖÒÕ¡¢ºÏ³ÉÒßÃçÊÖÒÕ¡¢ÂѰ׽ṹÉè¼ÆºÍVLP×é×°ÊÖÒÕ¡¢mRNAÊÖÒÕ¡¢ÖƼÁ¼°¸øÒ©ÊÖÒÕÎå´óÁ¢ÒìÒßÃçƽ̨ÊÖÒÕ¡£¡£ ¡£ÏÖÔÚÒѽ¨ÉèÁýÕÖ10ÓàÖÖ˳Ӧ֢µÄ¶à¿îÁ¢ÒìÒßÃç²úÆ·£¬£¬ £¬°üÀ¨ÑÇÖÞÊ׿îËļÛÁ÷ÄÔÁ¬ÏµÒßÃçÂüº£ÐÀ?¡¢¶þ¼ÛÁ÷ÄÔÁ¬ÏµÒßÃçÃÀÄÎϲ?¡¢»ñµÃÊÀÎÀ×éÖ¯ÈϿɵÄйÚÒßÃç¿ËÍþɯ?¡¢È«ÇòÊ׿îÎüÈëÓÃйÚÒßÃç¿ËÍþɯ?ÎíÓÅ?ÒÔ¼°ÑÇÖÞÊ׸öÖØ×é°£²©À­²¡¶¾²¡ÒßÃç¡£¡£ ¡£

 

Reference

[1] Wu W, Klockow JL, Zhang M, Lafortune F, Chang E, Jin L, Wu Y, Daldrup-Link HE. Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance. Pharmacol Res. 2021 Sep;171:105780. doi: 10.1016/j.phrs.2021.105780. Epub 2021 Jul 21. PMID: 34302977; PMCID: PMC8384724.

[2] mRNA Vaccine Boosts Immune Response Against Glioblastoma - NCI

[3] Karimi-Sani I, Molavi Z, Naderi S, Mirmajidi SH, Zare I, Naeimzadeh Y, Mansouri A, Tajbakhsh A, Savardashtaki A, Sahebkar A. Personalized mRNA vaccines in glioblastoma therapy: from rational design to clinical trials. J Nanobiotechnology. 2024 Oct 4;22(1):601. doi: 10.1186/s12951-024-02882-x. PMID: 39367418; PMCID: PMC11453023.

Òªº¦´Ê£º

ÉÏÒ»Ò³

еÃÀû¿Æ¼¼£¨688356.SH£©KT-001ºÍHO-PEG2000-DMG»®·Öͨ¹ýFDA¡¢CDE±¸°¸

ÏÂÒ»Ò³

ÉÏÒ»Ò³£º

ÏÂÒ»Ò³£º

еÃÀû¿Æ¼¼£¨688356.SH£©KT-001ºÍHO-PEG2000-DMG»®·Öͨ¹ýFDA¡¢CDE±¸°¸

ÍƼöÐÂÎÅ

еÃÀû¿Æ¼¼£¨688356.SH£©KT-001ºÍHO-PEG2000-DMG»®·Öͨ¹ýFDA¡¢CDE±¸°¸

2025-03-06

µÚ¶þ½ì¡°¿­·ç±­¡±´óѧÉúÉúÎïÒ½Ò©Á¢Òì´óÈüÔ²ÂúÊÕ¹Ù

2024-12-26

еÃÀû¿Æ¼¼£¨688356.SH£©Ìæ¶û²´ëIJàÁ´ tBuO-ICO-Glu(AEEA-AEEA-OH)-OtBu »ñFDAµÄDMF±¸°¸

2024-12-19

·ÖÏíµ½

¡¾ÍøÕ¾µØͼ¡¿¡¾sitemap¡¿